{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:46:09Z","timestamp":1774511169824,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T00:00:00Z","timestamp":1334966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s13181-012-0232-4","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T21:22:25Z","timestamp":1334956945000},"page":"310-313","source":"Crossref","is-referenced-by-count":74,"title":["Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification"],"prefix":"10.1007","volume":"8","author":[{"given":"Stephen L.","family":"Thornton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy R.","family":"Gerona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,21]]},"reference":[{"issue":"19","key":"232_CR1","first-page":"624","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC) (2011) Emergency department visits after use of a drug sold as \"bath salts\"\u2014Michigan, November 13, 2010\u2013March 31, 2011. MMWR Morb Mortal Wkly Rep 60(19):624\u2013627","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"232_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG et al (2011) Clinical experience with and analytical confirmation of \"bath salts\" and \"legal highs\" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49(6):499\u2013505","journal-title":"Clin Toxicol (Phila)"},{"key":"232_CR3","doi-asserted-by":"crossref","unstructured":"Reitzel LA, Dalsgaard PW, M\u00fcller IB, et al. (2012) Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish Internet company. Drug Test Anal (in press)","DOI":"10.1002\/dta.358"},{"issue":"6","key":"232_CR4","first-page":"640","volume":"33","author":"JL Antonowicz","year":"2011","unstructured":"Antonowicz JL, Metzger AK, Ramanujam SL (2011) Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 33(6):640","journal-title":"Gen Hosp Psychiatry"},{"key":"232_CR5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/15563650.2011.598695","volume":"49","author":"JW Spencer","year":"2011","unstructured":"Spencer JW, Long C, Scalzo AJ et al (2011) Acute psychiatric, cardiopulmonary, and neurologic effects of laboratory-confirmed use of methylenedioxypyrovalerone (MDPV) \u201cbath salts\u201d. (Abstract). Clin Toxicol (Phila) 49:515\u2013627","journal-title":"Clin Toxicol (Phila)"},{"key":"232_CR6","doi-asserted-by":"crossref","unstructured":"Lung DD, Gerona RR, Wu AH, et al (2012) Confirmed glyburide poisoning from ingestion of \"Street Valium\". J Emerg Med (in press)","DOI":"10.1016\/j.jemermed.2011.06.019"},{"issue":"1","key":"232_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-8223(21)39775-9","volume":"74","author":"ML Bunker","year":"1979","unstructured":"Bunker ML, McWilliams M (1979) Caffeine content of common beverages. J Am Diet Assoc 74(1):28\u201332","journal-title":"J Am Diet Assoc"},{"issue":"7","key":"232_CR8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","volume":"106","author":"KM Morefield","year":"2011","unstructured":"Morefield KM, Keane M, Felgate P et al (2011) Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users. Addiction 106(7):1293\u20131300","journal-title":"Addiction"},{"issue":"8","key":"232_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/dta.155","volume":"2","author":"SD Brandt","year":"2010","unstructured":"Brandt SD, Sumnall HR, Measham F et al (2010) Analyses of second-generation \u2018legal highs\u2019 in the UK: initial findings. Drug Test Anal 2(8):377\u2013382","journal-title":"Drug Test Anal"},{"issue":"204","key":"232_CR10","first-page":"65371","volume":"76","author":"Drug Enforcement Administration (DEA)","year":"2011","unstructured":"Drug Enforcement Administration (DEA) (2011) Department of Justice. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final order. Fed Regist 76(204):65371\u201365375","journal-title":"Fed Regist"},{"issue":"2\u20133","key":"232_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejphar.2011.10.033","volume":"674","author":"S Yubero-Lahoz","year":"2012","unstructured":"Yubero-Lahoz S, Ayestas MA Jr, Blough BE et al (2012) Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain. Eur J Pharmacol 674(2\u20133):337\u2013344","journal-title":"Eur J Pharmacol"},{"key":"232_CR12","doi-asserted-by":"crossref","unstructured":"Mugele J, Na\u00f1agas KA, Tormoehlen LM (2012) Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med (in press)","DOI":"10.1016\/j.annemergmed.2011.11.033"},{"issue":"2","key":"232_CR13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM et al (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339(2):530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"232_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","volume":"8","author":"BL Murray","year":"2012","unstructured":"Murray BL, Murphy CM, Beuhler MC (2012) Death following recreational use of designer drug \"bath salts\" containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 8(1):69\u201375","journal-title":"J Med Toxicol"},{"key":"232_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1749-6632.1978.tb31518.x","volume":"305","author":"RW Fuller","year":"1978","unstructured":"Fuller RW (1978) Structure-activity relationships among the halogenated amphetamines. Ann N Y Acad Sci 305:147\u2013159","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"232_CR16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","volume":"45","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Du P, Schuster F et al (2010) Studies on the metabolism of the \u03b1 pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45(12):1426\u20131442","journal-title":"J Mass Spectrom"},{"key":"232_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00414-011-0601-6","volume":"26","author":"E Pawlik","year":"2012","unstructured":"Pawlik E, Pl\u00e4sser G, Mahler H et al (2012) Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices. Int J Legal Med 26:231\u2013240","journal-title":"Int J Legal Med"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-012-0232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-012-0232-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-012-0232-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T13:53:30Z","timestamp":1642082010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-012-0232-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,21]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1007\/s13181-012-0232-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,21]]}}}